ENDRA Life Sciences (NDRA) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on ENDRA Life Sciences (NDRA) is Neutral.

The composite score behind that read is -0.18, weighing +0.06 of bullish evidence against -0.45 bearish.

ENDRA Life Sciences last closed at $5.46, -7.93% on the session.

Against the IVW growth benchmark the position is -8.73% over the forecast window.

The read is built from 15 underlying insights — 2 bullish and 13 bearish.

Agreement across those insights is 87%.

20 graded predictions for NDRA so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks ENDRA Life Sciences in the 4th percentile on return on equity, where 100 is best.

ENDRA Life Sciences is classified under Health Care / Health Care Equipment & Supplies, with a market capitalisation of $8.89M.

StockMap tracks ENDRA Life Sciences as the 133rd largest of the 140 companies it covers in the Health Care Equipment & Supplies industry, part of the Health Care sector.

Across that group the current two-week reads are 122 Neutral, 16 Moderate Underperform and 2 Moderate Outperform.

On that composite ENDRA Life Sciences ranks 117th of 140 in the group, against a group median of -0.03.